Skip to content

The TELEAP1 CPAP-telemonitoring Study

Evaluation of a CPAP Telemonitoring Algorithm for Newly Treated Patients: the TELEAP1 Multicenter Cohort Pilot Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04897646
Acronym
TELEAP1
Enrollment
300
Registered
2021-05-21
Start date
2021-05-01
Completion date
2023-12-15
Last updated
2021-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Keywords

Obstructive Sleep apnea, Continuous Positive Airway Pressure,, Telemedicine, COVID 19, observance, leaks, apnea hypopnea index.

Brief summary

TELEAP1 is a multicenter cohort pilot-study designed to evaluate the impact of a published SFRMS/SPLF CPAP-telemonitoring diagnosis/therapeutic algorithm on the CPAP-compliance of newly treated patients with obstructive sleep apnea..

Detailed description

Continuous Positive Airway Pressure (CPAP)-devices can track compliance, but also leaks and residual Apnea-Hypopnea-Index (AHIflow) values. CPAP tracking systems seem intuitively useful, but there are few data demonstrating the benefit of such systems in improving CPAP-compliance and/or patients quality of life. In 2020, a working group from the Société Française de Recherche et de Médecine du Sommeil (SFRMS) and the Société de Pneumologie de Langue Française (SPLF) have proposed a CPAP-telemonitoring diagnosis/therapeutic algorithm for newly treated patients with obstructive sleep apnea. In order to describe and evaluate the impact of this SFRMS/SPLF-algorithm (not only on the patient but also on the home care provider activity), a one year multicenter cohort pilot-study (TELAP1-study) was set up.

Interventions

OTHERSFRMS/SPLF CPAP-telemonitoring diagnosis/therapeutic algorithm.

In 2020, a working group from the Société Française de Recherche et de Médecine du Sommeil (SFRMS) and the Société de Pneumologie de Langue Française (SPLF) have proposed a CPAP-telemonitoring diagnosis/therapeutic algorithm for newly treated patients with obstructive sleep apnea. The algorithm is exhasutively described in the following published article: Prigent, A., Gentina, T., Launois, S., et al. \[Telemonitoring in continuous positive airway pressure-treated patients with obstructive sleep apnoea syndrome: An algorithm proposal\]. Rev. Mal. Respir., 2020, 37: 550-560.

Sponsors

ADENE, Montpellier
CollaboratorUNKNOWN
AGIR à dom, Meylan
CollaboratorUNKNOWN
ASTEN sante, Pays de la Loire
CollaboratorUNKNOWN
ELIA medical, Cesson-Sévigné
CollaboratorUNKNOWN
University Hospital, Montpellier
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years of age or older * Patient newly CPAP-treated and eligible for care and for the reimbursement by the French Social Security rules * Signed informed consent

Exclusion criteria

* Previous CPAP-treatment * Pregnancy * Inability to understand the nature and aims of the study or to communicate with the investigator * Simultaneous participation in another trial with an exclusion clause to participate in another trial * No affiliation with the French social security regime * Loss of personal capacity resulting in state protection * Deprivation of liberty by judicial or administrative decision

Design outcomes

Primary

MeasureTime frameDescription
CPAP-complianceversus corresponding 2019 weeks (h/days)4 monthsCPAP-compliance (hour/day) reported by the CPAP-software for the last 28 days

Secondary

MeasureTime frameDescription
CPAP-adherence12 monthsCPAP-adherence defined as the % of patients with a CPAP-adherence \>4h/day, CPAP-adherence reported by the CPAP-software for the last 28 days.
CPAP-leaks4 monthsimportant leaks (l/min or % or min/days) reported by the CPAP-software for the last 28 days
Patient subjective sleepiness4 monthsreported by the patient using the Epworth Sleepiness Scale (0-24)
Patient subjective depression12 monthsreported by the patient using the Pichot Depression Scale (0-13)
Unplanned patient phone callDay 0 to 360unplanned patient phone call with the technician regardless of the reason
Patient subjective insomnia4 monthsreported by the patient using the Insomnia Severity Scale (0-28)
CPAP-compliance12 monthsCPAP-compliance (hour/day) reported by the CPAP-software for the last 28 days
AHIflow4 monthsAHIflow (events/hour) reported by the CPAP-software for the last 28 days
Unplanned patient visitDay 0 to 360unplanned patient visit to the care provider regardless of the reason
Unplanned technician visitDay 0 to 360unplanned technician visit to the patient regardless of the reason
CPAP telemonitoring alarmDay 0 to 360number and type (cpap observance \< 4h for the last 7 days, and or IAHflow \>10/h for the last 7 days, and or important leaks for the last 7 days)
Interface-type changeDay 0 to 360description of the interface-type change (nasal, nasal pillows, oronasal) regardless of the reason
Pressure settings modificationDay 0 to 360Change in the CPAP-pressure settings regardless of the reason
CPAP-mode modificationDay 0 to 360Change in the CPAP mode (constant or auto-CPAP) regardless of the reason
Unplanned technician phone callDay 0 to 360unplanned technician phone call with the patient regardless of the reason

Countries

France

Contacts

Primary ContactDany Jaffuel, MD, PhD
dany.jaffuel@wanadoo.fr+33467314840
Backup ContactArnaud Prigent, MD
a.prigent@stv-stlaurent.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026